Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001641172-25-025446

Director bought 125,000 shares at $2.00 ($250,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Leftwich Scott Director 2025-08-21 Purchase +125,000 $2.00 $250,000 130,650 D
Derivatives
Leftwich Scott Director 2025-08-21 Purchase · Warrant (right to buy) +125,000 125,000 D
Open-market purchases · 125,000 sh · avg $2.00 · $250,000
Loading xslF345X05/ownership.xml…